Suz Redfearn

1 month ago | gazettextra.com | Suz Redfearn

“Breaking news: The Trump administration just announced that Medicare will stop covering telehealth starting April 1. … We need to stand up to these Medicare cuts.”Rep. Ro. Khanna (D-Calif.), in a TikTok video posted Feb. 20, 2025k9C ^mkAm#6A] #@ z92??2[ s\r2=:7][ k2 9C67lQ9EEADi^^HHH]E:<E@<]4@>^oC6AC@<92??2^G:56@^fcfbe__gf`b_e`begfcn0Cl`U2>Aj0El+%\gFd=4!ztfxbQmA@DE65 2 %:<E@< G:56@k^2m @?

1 month ago | indiacurrents.com | Suz Redfearn

Rep. Ro Khanna (D-Calif.) posted a Tiktok video on Feb. 20 saying he had “breaking news” about the fate of Medicare coverage for telehealth visits, which allow patients to see health care providers remotely from their homes. “Breaking news: The Trump administration just announced that Medicare will stop covering telehealth starting April 1,” Khanna said.

1 month ago | politifact.com | Suz Redfearn

U.S. Rep. Ro Khanna, D-Calif., posted a TikTok video Feb. 20 saying he had "breaking news" about the fate of Medicare coverage for telehealth visits, which allow patients to see health care providers remotely from their homes. "Breaking news: The Trump Administration just announced that Medicare will stop covering telehealth starting April 1," Khanna said.

1 month ago | kffhealthnews.org | Suz Redfearn

Thank you for your interest in supporting Kaiser Health News (KHN), the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support. KHN is an editorially independent program of KFF (Kaiser Family Foundation).

Aug 23, 2024 | mprnews.org | Suz Redfearn

A potentially ground-breaking nose-spray version of the drug epinephrine will soon hit the market — an alternative to auto-injectors like EpiPen for people having serious allergic reactions. The drug was approved this month by the FDA for use in adults and older children. But some allergists say they’re not in a hurry to prescribe it.